Literature DB >> 1951837

Recent trends in the incidence of toxic shock syndrome in northern California.

D B Petitti1, A L Reingold.   

Abstract

The incidence of toxic shock syndrome in women members of a large prepaid medical care program in Northern California was 1.5 cases per 100,000 in a period after removal of tampons containing polyacrylate rayon and reductions in tampon absorbency. This rate was lower, but not significantly lower, than the rate of 2.2 per 100,000 in the prior interval. It was higher, but not significantly higher, than the rate of 0.4 per 100,000 in the era before "superabsorbent" materials were introduced into tampons. The incidence in men has been stable at about 0.1 cases per 100,000 for the 15-year period from 1972 though 1987.

Entities:  

Mesh:

Year:  1991        PMID: 1951837      PMCID: PMC1405656          DOI: 10.2105/ajph.81.9.1209

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  3 in total

1.  Tampon characteristics and menstrual toxic shock syndrome.

Authors:  D B Petitti; A Reingold
Journal:  JAMA       Date:  1988-02-05       Impact factor: 56.272

2.  The relationship of tampon characteristics to menstrual toxic shock syndrome.

Authors:  S F Berkley; A W Hightower; C V Broome; A L Reingold
Journal:  JAMA       Date:  1987-08-21       Impact factor: 56.272

3.  The incidence of toxic shock syndrome in Northern California. 1972 through 1983.

Authors:  D B Petitti; A Reingold; J Chin
Journal:  JAMA       Date:  1986-01-17       Impact factor: 56.272

  3 in total
  2 in total

Review 1.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

2.  Infectious shock and toxic shock syndrome diagnoses in hospitals, Colorado, USA.

Authors:  Michael A Smit; Ann-Christine Nyquist; James K Todd
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.